A new messenger ribonucleic acid (mRNA) vaccine developed to prevent all 20 types of seasonal influenza viruses (commonly known as influenza) has been successful in animal experiments.
As a result, hopes have risen that a ‘universal flu vaccine’ can be realized that can prevent all types of seasonal flu with a single vaccine. However, it is not yet known what the results will be in human clinical trials.
‘Science’, a leading scientific journal published by the American Association for the Advancement of Science (AAAS), published a paper titled ‘A multiple nucleoside-modified mRNA vaccine that inhibits all known influenza virus subtypes’ in its latest issue and published on the 25th.
The research team designed an mRNA vaccine that can prevent 20 influenza viruses using lipid nanoparticle technology, and it was found to be effective as a result of animal experiments with mice (mice) and ferrets (rabbits).
